Penyakit Graves pada Anak Perempuan Usia 10 Tahun
DOI:
https://doi.org/10.55175/cdk.v49i5.234Keywords:
Autoimun, Penyakit GravesAbstract
Penyakit Graves (PG) adalah penyakit autoimun akibat pembentukan antibodi TSH receptor-stimulating immunoglobulin (TSI) yang menyebabkan produksi hormon tiroid meningkat. Seorang anak perempuan, usia 10 tahun, dengan benjolan pada leher bagian kanan dan kiri depan yang baru disadari sejak 3 hari, tidak nyeri. Prestasi belajar seperti biasa. Tangannya bergetar ringan saat menulis. Penyakit Graves didiagnosis berdasarkan pemeriksaan fisik dan ultrasonografi tiroid, fungsi tiroid, dan pemeriksaan antibodi tiroid. Terapi dengan methimazole tablet 5 mg setiap 12 jam dan kontrol FT4 dan TSH setelah 1 bulan.
Graves’ disease is an autoimmune disease with formation of TSH receptor-stimulating immunoglobulin (TSI) antibodies resulting in increased thyroid hormone production. A 10 year-old girl with a painless lump in the right and left side of her anterior neck, noticed since 3 days ago. Learning achievement is still good. Her hands were slightly trembling while writing. Graves’ disease was diagnosed based on physical examination and thyroid ultrasound, thyroid function, and thyroid antibody tests. The treatment was methimazole 5 mg tablets every 12 hours and laboratory check for FT4 and TSH after 1 month.
Downloads
References
Radovick S, Isra M, editors. Pediatric endocrinology: A practical clinical guide. Berlin, Jerman: Springer; 2018.
Leger J, Kaguelidou F, Alberti C, Carel JC. Graves’ disease in children. Best Pract Res Clin Endocrinol Metab. 2014;28:233-43.
Gastaldi R, Poggi E, Mussa A, Weber G, Vigone MC, Salerno M, et al. Graves disease in children: Thyroid-stimulating hormone receptor antibodies as remission markers. J Pediatr. 2014;164(5):1189-94.
LaFranchi S. Clinical manifestations and diagnosis of Graves disease in children and adolescents. UpToDate [Internet]. [cited 2020 Jul 29]. Available from: https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-graves-disease-in-children-and-adolescents.
Conference Proc: Hepatic toxicity following treatment for pediatric Graves’ disease meeting, October 28 2008. Eunice Kennedy Shriver National Institute of Child Health and Human Development; 2009.
Leger J, et al. IMPE meeting. Washington; 2017.
Panduan praktik klinis Ikatan Dokter Anak Indonesia diagnosis dan tata laksana hipertiroid. Jakarta: IDAI; 2017.
Kaplowitz PB, Vaidyanathan P. Update on pediatric hyperthyroidism. Curr Op Endocrinol, Diabetes Obes, 2020;27(1):70-6.
Chiang Y, Ting W, Huang C, Huang S, Chan C, Cheng B, et al. Long-term outcomes of Graves disease in children treated with anti-thyroid drugs. Pediatr Neonatol. 2020;61:311-7.
Minamitani K, Sato H, Ohye H, Harada S, Arisaka O. Guidelines for the treatment of childhood-onset Graves’ disease in Japan, 2016. Clin Pediatr Endocrinol. 2017;26(2):29-62.
Rusda H, Oenzil F, Alioes Y. Hubungan kadar fT4 dengan kejadian tirotoksikosis berdasarkan penilaian indeks New Castle pada wanita dewasa di daerah ekses yodium. J Kes Andalas 2013;2(2):85-9.
Boelaert K, Franklyn JA. Thyrotoxicosis. Lancet 2012;379(9821):1155-66
Williamson S, Greene SA. Incidence of thyrotoxicosis in childhood: A national population based study in the UK and Ireland. Clin Endocrinol (Oxf ). 2010;72(3):358-63.
Bauer AJ. Approach to the pediatric patient with Graves’ disease: when is definitive therapy warranted? J Clin Endocrinol Metab. 2011;96(3):580-8.
Sims EK, Eugster EA, Nebesio TD. Detours on the road to diagnosis of Graves disease. Clin Pediatr (Phila). 2012;51(2):160-4.
Hanley P, Lord K, Bauer AJ. Thyroid disorders in children and adolescents: A review. JAMA Pediatr. 2016;170(10):1008-19.
Kotwal A, Stan M. Thyrotropin receptor antibodies - an overview. Ophthalmic Plastic Reconstructive Surg. 2018;34(4S):20-7.
Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 2016;26:1343–421.
Baskaran C, Misra M, Levitsky LL. Diagnosis of pediatric hyperthyroidism: Technetium 99 uptake vs thyroid stimulating immunoglobulins. Thyroid 2015;25(1):37-42.
Leger J, Oliver I, Rodrigue D, Lambert AS, Coutant R. Graves' disease in children. Ann Endocrinol (Paris). 2018;79(6):647-55. https://doi.org/10.1016/j.ando.2018.08.001.
Goichot B, Leenhardt L, Massart C, Raverot V, Tramalloni J, Iraqi H, et al. Diagnostic procedure in suspected Graves' disease. Ann Endocrinol (Paris). 2018;79(6):608-17.
Vita R, Di Bari F, Perelli S, Capodicasa G, Benvenga S. Thyroid vascularization is an important ultrasonographic parameter in untreated Graves’ disease patients. J Clin Translat Endocrinol. 2019;15:65-9.
Yasuda K, Miyoshi Y, Tachibana M, Namba N, Miki K, Nakata Y. Relationship between dose of hyperthyroid drugs and adverse events in pediatric patients with Graves’ disease. Clin Pediatr Endocrinol. 2017;26(1):1-7.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
